UniProt ID | ST7_HUMAN | |
---|---|---|
UniProt AC | Q9NRC1 | |
Protein Name | Suppressor of tumorigenicity 7 protein | |
Gene Name | ST7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 585 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
Protein Description | May act as a tumor suppressor.. | |
Protein Sequence | MAEAATGFLEQLKSCIVWSWTYLWTVWFFIVLFLVYILRVPLKINDNLSTVSMFLNTLTPKFYVALTGTSSLISGLILIFEWWYFRKYGTSFIEQVSVSHLRPLLGGVDNNSSNNSNSSNGDSDSNRQSVSECKVWRNPLNLFRGAEYNRYTWVTGREPLTYYDMNLSAQDHQTFFTCDSDHLRPADAIMQKAWRERNPQARISAAHEALEINEIRSRVEVPLIASSTIWEIKLLPKCATAYILLAEEEATTIAEAEKLFKQALKAGDGCYRRSQQLQHHGSQYEAQHRRDTNVLVYIKRRLAMCARRLGRTREAVKMMRDLMKEFPLLSMFNIHENLLEALLELQAYADVQAVLAKYDDISLPKSATICYTAALLKARAVSDKFSPEAASRRGLSTAEMNAVEAIHRAVEFNPHVPKYLLEMKSLILPPEHILKRGDSEAIAYAFFHLAHWKRVEGALNLLHCTWEGTFRMIPYPLEKGHLFYPYPICTETADRELLPSFHEVSVYPKKELPFFILFTAGLCSFTAMLALLTHQFPELMGVFAKAMIDIFCSAEFRDWNCKSIFMRVEDELEIPPAPQSQHFQN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | WSWTYLWTVWFFIVL HHHHHHHHHHHHHHH | 12.79 | 26074081 | |
36 | Phosphorylation | FIVLFLVYILRVPLK HHHHHHHHHHHCCCC | 9.08 | 26074081 | |
47 | N-linked_Glycosylation | VPLKINDNLSTVSMF CCCCCCCCHHHHHHH | 31.25 | UniProtKB CARBOHYD | |
49 | Phosphorylation | LKINDNLSTVSMFLN CCCCCCHHHHHHHHH | 32.77 | 22210691 | |
50 | Phosphorylation | KINDNLSTVSMFLNT CCCCCHHHHHHHHHH | 21.55 | 22210691 | |
52 | Phosphorylation | NDNLSTVSMFLNTLT CCCHHHHHHHHHHCC | 12.14 | 22210691 | |
57 | Phosphorylation | TVSMFLNTLTPKFYV HHHHHHHHCCCCEEE | 33.87 | 23663014 | |
67 | Phosphorylation | PKFYVALTGTSSLIS CCEEEEHHCCHHHHH | 28.77 | 22210691 | |
69 | Phosphorylation | FYVALTGTSSLISGL EEEEHHCCHHHHHHH | 15.20 | 22210691 | |
88 | Phosphorylation | EWWYFRKYGTSFIEQ HHHHHHHHCCCHHEE | 22.75 | 27732954 | |
90 | Phosphorylation | WYFRKYGTSFIEQVS HHHHHHCCCHHEEEE | 19.85 | 27732954 | |
91 | Phosphorylation | YFRKYGTSFIEQVSV HHHHHCCCHHEEEEH | 21.62 | 27732954 | |
97 | Phosphorylation | TSFIEQVSVSHLRPL CCHHEEEEHHHHHHC | 20.00 | 27732954 | |
99 | Phosphorylation | FIEQVSVSHLRPLLG HHEEEEHHHHHHCCC | 14.86 | 24719451 | |
261 | Ubiquitination | AEAEKLFKQALKAGD HHHHHHHHHHHHHCC | 45.13 | - | |
265 | Ubiquitination | KLFKQALKAGDGCYR HHHHHHHHHCCCCHH | 54.03 | - | |
304 (in isoform 6) | Ubiquitination | - | 1.86 | 21890473 | |
311 (in isoform 6) | Ubiquitination | - | 34.89 | 21890473 | |
331 (in isoform 5) | Ubiquitination | - | 2.77 | 21890473 | |
338 (in isoform 5) | Ubiquitination | - | 4.10 | 21890473 | |
345 (in isoform 6) | Ubiquitination | - | 3.40 | 21890473 | |
347 (in isoform 3) | Ubiquitination | - | 17.69 | 21890473 | |
354 (in isoform 7) | Ubiquitination | - | 2.74 | 21890473 | |
354 (in isoform 3) | Ubiquitination | - | 2.74 | 21890473 | |
354 (in isoform 2) | Ubiquitination | - | 2.74 | 21890473 | |
358 | Phosphorylation | VQAVLAKYDDISLPK HHHHHHHCCCCCCCC | 17.15 | - | |
361 (in isoform 7) | Ubiquitination | - | 4.10 | 21890473 | |
361 (in isoform 2) | Ubiquitination | - | 4.10 | 21890473 | |
362 | Phosphorylation | LAKYDDISLPKSATI HHHCCCCCCCCCHHH | 45.68 | 24719451 | |
372 (in isoform 5) | Ubiquitination | - | 10.88 | 21890473 | |
377 | Ubiquitination | CYTAALLKARAVSDK HHHHHHHHHHHCCCC | 36.35 | 21890473 | |
377 (in isoform 4) | Ubiquitination | - | 36.35 | 21890473 | |
377 (in isoform 1) | Ubiquitination | - | 36.35 | 21890473 | |
382 | Phosphorylation | LLKARAVSDKFSPEA HHHHHHCCCCCCHHH | 33.81 | 23186163 | |
384 (in isoform 1) | Ubiquitination | - | 39.99 | 21890473 | |
384 (in isoform 4) | Ubiquitination | - | 39.99 | 21890473 | |
384 | Ubiquitination | KARAVSDKFSPEAAS HHHHCCCCCCHHHHH | 39.99 | 21890473 | |
386 | Phosphorylation | RAVSDKFSPEAASRR HHCCCCCCHHHHHHC | 27.80 | 10889047 | |
388 (in isoform 3) | Ubiquitination | - | 56.52 | 21890473 | |
391 | Phosphorylation | KFSPEAASRRGLSTA CCCHHHHHHCCCCHH | 29.56 | 19691289 | |
395 (in isoform 2) | Ubiquitination | - | 3.79 | 21890473 | |
395 (in isoform 7) | Ubiquitination | - | 3.79 | 21890473 | |
396 | Phosphorylation | AASRRGLSTAEMNAV HHHHCCCCHHHHHHH | 28.53 | - | |
397 | Phosphorylation | ASRRGLSTAEMNAVE HHHCCCCHHHHHHHH | 31.51 | - | |
418 (in isoform 1) | Ubiquitination | - | 47.65 | 21890473 | |
418 (in isoform 4) | Ubiquitination | - | 47.65 | 21890473 | |
418 | Ubiquitination | EFNPHVPKYLLEMKS HHCCCCCHHHHHHHH | 47.65 | 21890473 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ST7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ST7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ST7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-386, AND MASSSPECTROMETRY. |